Nvidia Corp vs TransMedics Group Inc — how do they compare? Nvidia Corp trades at $206.35 (market cap $4.92T), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Nvidia Corp is far larger — about 1937× TransMedics Group Inc's market cap, and Nvidia Corp pays a 0.49% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NVDA | TMDX | |
|---|---|---|
Market Cap | $4.92T | $2.54B |
Sector | Technology | Technology |
52-Week High | $235.75 | $150.42 |
52-Week Low | $165.17 | $61.99 |
Enterprise Value | $4.86T | $2.94B |
Dividend Yield | 0.49% | — |
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $207.14, up 2.14% today, with a neutral technical signal and strong fundamentals. Recent earnings beats and robust profitability margins highlight operational strength. The stock is supported by a consensus analyst price target of $325.86, though it faces technical resistance near $210.
Outlook remains positive driven by AI chip demand, but risks include competition and market volatility. Revenue growth acceleration and high institutional ownership suggest long-term potential, yet valuation multiples require sustained execution to justify further upside.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →